|
|
|
C-JUN N-TERMINAL KINASES MAPK SIGNALING PATHWAY (PW:0000313)
DescriptionThe c-Jun N-terminal
kinase pathway (Jnk), known as a stress activated protein kinase pathway
(SAPK), responds to inflammatory cytokines and various stresses and to a lesser
degree to growth factors. Jnk displays the characteristic three-tier core
cascade MAPK architecture. The downstream and effector MAPK tier (here Jnk1-3
represented by Mapk8-10) is activated by phosphorylation of threonine and
tyrosine residues within the conserved TPY motif in the activation loop by dual
specificity kinases of the middle MAP2K tier (here Mkk4 and Mkk7 - Map2k4 and 7,
respectively), in turn activated by the upstream MAP3K tier. Interestingly, 14
out of about 20 Map3ks can activate the Mkk4/7 middle tier. While some are
specific for Jnk pathway, others can activate both Jnk and the p38 MAPK pathway
(the other SAPK), a few activate both Jnk and either Raf/Mek/Erk or Erk5 MAPK
pathways. Some of Map3ks may be activated by small monomeric G-proteins,
particularly by members of the Rho
family (eg. Rac1 and Cdc42); others by interaction with adapter bound proteins
downstream of cytokine receptors (eg. Traf2). Out of the three Jnk genes of the
MAPK tier, two are ubiquitously expressed (Mapk8/Jnk1 and Mapk9/Jnk2) while
Mapk10/Jnk3 appears to be restricted only to certain tissues. The MAPKs are
serine/threonine kinases with a broad repertoire of targets that include
transcription factors and other nuclear proteins; among the non-nuclear targets
there are members of the intrinsic apoptotic pathway and structural proteins.
Several scaffold proteins mediate the organization of components and regulate the
functioning of the pathway. The family of Jip proteins has been shown to act as
scaffolds for Jnk; the second member might also act as a scaffold for p38 Mapk
cascade. They use their C-terminal regions to interact with kinases of the
first and second tier and N-terminal regions to interact with Mapks of the last
tier (schematically represented in the diagram). Dual specificity phosphatases
such as Dusp8/M3/6, Dusp10/Mkp-5, Dusp16/Mkp-7 and possibly Dusp1/Mkp-1
negatively regulate the pathway but the exact mechanisms thereby this is
accomplished are still elusive. Some Mkp members are inactive in the absence of
the substrate. Binding of the substrate alters the structure of the DUSP ( DSPc
domain) phosphatase domain, rendering the enzyme catalytically active. Dusp8,
10 and 16 are type III family members that localize both in the cytoplasm and
nucleus. Processes regulated by JNK pathway include proliferation, motility,
inflammatory response, apoptosis; deregulation of the pathway is associated
with several human diseases. To see the ontology report for annotations, GViewer and
download, click here[click to see related GO term ¿ GO:0007254 and KEGG map ¿ map04010...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
c-Jun N-terminal kinases MAPK signaling pathway
|
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
|
ISS |
5 |
156,106,123 |
156,143,040 |
RGD:2293879 |
RGD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
|
ISS |
5 |
156,106,123 |
156,143,040 |
RGD:2293876 |
RGD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
|
ISS |
10 |
16,942,913 |
16,945,696 |
RGD:2293881 |
RGD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
|
ISS |
13 |
100,022,421 |
100,059,539 |
RGD:2293881 |
RGD |
| G |
Dusp16 |
dual specificity phosphatase 16 |
|
|
ISS |
4 |
171,620,395 |
171,667,593 |
RGD:2293881 |
RGD |
| G |
Dusp19 |
dual specificity phosphatase 19 |
|
|
ISS |
3 |
63,473,333 |
63,485,843 |
RGD:2314491 |
RGD |
| G |
Dusp8 |
dual specificity phosphatase 8 |
|
|
ISS |
1 |
202,215,086 |
202,229,746 |
RGD:2293881 |
RGD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
|
IDA |
10 |
52,009,149 |
52,041,599 |
RGD:2298577 |
RGD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
|
IDA |
10 |
52,009,149 |
52,041,599 |
RGD:2298708 |
RGD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
|
ISS |
10 |
52,009,149 |
52,041,599 |
RGD:2298561 |
RGD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
|
ISS |
10 |
52,009,149 |
52,041,599 |
RGD:2293875 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
IDA |
12 |
1,545,407 |
1,552,353 |
RGD:2298577 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
ISS |
12 |
1,545,407 |
1,552,353 |
RGD:2293875 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
IDA |
12 |
1,545,407 |
1,552,353 |
RGD:2298567 |
RGD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
|
IDA |
12 |
1,545,407 |
1,552,353 |
RGD:2298561 |
RGD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
|
ISS |
2 |
43,062,252 |
43,126,058 |
RGD:2293879 |
RGD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
|
ISS |
2 |
43,062,252 |
43,126,058 |
RGD:2293875 |
RGD |
| G |
Map3k10 |
mitogen activated protein kinase kinase kinase 10 |
|
|
ISS |
1 |
82,750,424 |
82,768,725 |
RGD:2293875 |
RGD |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
|
IDA |
1 |
208,312,955 |
208,326,289 |
RGD:2298577 |
RGD |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
|
IDA |
1 |
208,312,955 |
208,326,289 |
RGD:2298567 |
RGD |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
|
ISS |
1 |
208,312,955 |
208,326,289 |
RGD:2293875 |
RGD |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
|
ISS |
1 |
208,312,955 |
208,326,289 |
RGD:2293876 |
RGD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
|
ISS |
7 |
141,254,451 |
141,264,979 |
RGD:2293875 |
RGD |
| G |
Map3k2 |
mitogen activated protein kinase kinase kinase 2 |
|
|
ISS |
18 |
24,606,219 |
24,672,732 |
RGD:2293875 |
RGD |
| G |
Map3k2 |
mitogen activated protein kinase kinase kinase 2 |
|
|
ISS |
18 |
24,606,219 |
24,672,732 |
RGD:2293879 |
RGD |
| G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
|
|
ISS |
10 |
95,482,303 |
95,551,065 |
RGD:2293875 |
RGD |
| G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
|
|
ISS |
10 |
95,482,303 |
95,551,065 |
RGD:2293879 |
RGD |
| G |
Map3k4 |
mitogen activated protein kinase kinase kinase 4 |
|
|
ISS |
1 |
42,891,172 |
42,978,862 |
RGD:2293875 |
RGD |
| G |
Map3k4 |
mitogen activated protein kinase kinase kinase 4 |
|
|
ISS |
1 |
42,891,172 |
42,978,862 |
RGD:2293879 |
RGD |
| G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
|
|
ISS |
5 |
48,252,637 |
48,308,820 |
RGD:2293875 |
RGD |
| G |
Map3k9 |
mitogen-activated protein kinase kinase kinase 9 |
|
|
ISS |
6 |
105,593,215 |
105,651,838 |
RGD:2293875 |
RGD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
|
IDA |
14 |
7,719,595 |
8,010,694 |
RGD:2298567 |
RGD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
|
IDA |
14 |
7,719,595 |
8,010,694 |
RGD:2298561 |
RGD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
|
ISS |
14 |
7,719,595 |
8,010,694 |
RGD:2293875 |
RGD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
|
IDA |
16 |
8,925,133 |
9,004,897 |
RGD:2298577 |
RGD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
|
ISS |
16 |
8,925,133 |
9,004,897 |
RGD:2298561 |
RGD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
|
ISS |
16 |
8,925,133 |
9,004,897 |
RGD:2293875 |
RGD |
| G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
|
|
IDA |
3 |
76,781,504 |
76,790,661 |
RGD:1579811 |
RGD |
| G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
|
|
ISS |
3 |
76,781,504 |
76,790,661 |
RGD:2293880 |
RGD |
| G |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
|
|
ISS |
7 |
127,773,156 |
127,780,772 |
RGD:2293880 |
RGD |
| G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
|
ISS |
10 |
14,147,895 |
14,186,277 |
RGD:2293880 |
RGD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
|
IDA |
10 |
35,353,486 |
35,384,319 |
RGD:2298577 |
RGD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
|
IDA |
10 |
35,353,486 |
35,384,319 |
RGD:2298561 |
RGD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
|
ISS |
10 |
35,353,486 |
35,384,319 |
RGD:2293875 |
RGD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
|
ISS |
12 |
11,380,314 |
11,400,531 |
RGD:2293879 |
RGD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
|
ISS |
12 |
11,380,314 |
11,400,531 |
RGD:2293876 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
|
|
|
RGD:1581337 |
RGD |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
|
ISS |
3 |
3,692,740 |
3,717,332 |
RGD:2296020 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the c-Jun N-terminal kinases MAPK signaling pathway
|
|
|
|
| Cdc42 | Alzheimer Disease , Arthritis, Experimental , Bipolar Disorder , Epilepsy, Temporal Lobe , Fibrosarcoma , Reperfusion Injury , Rhinitis , Spinal Cord Injuries | | Dusp10 | Pancreatitis | |
|
| Dusp1 | Anti-Glomerular Basement Membrane Disease , Arteriosclerosis , Breast Neoplasms , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 1 , Glucose Intolerance , Hypertension , Hypertension, Portal , Obesity , Ovarian Neoplasms , Pancreatitis , Prostatic Neoplasms , Seizures , Urinary Bladder Neoplasms | |
| Map2k4 | Carcinoma, Ductal, Breast , Ovarian Neoplasms , Pancreatic Neoplasms , Prostatic Intraepithelial Neoplasia , Prostatic Neoplasms , Pulmonary Disease, Chronic Obstructive , Urinary Bladder Neoplasms | | Map2k7 | Ovarian Neoplasms , Prostatic Intraepithelial Neoplasia , Prostatic Neoplasms | |
|
|
| Map3k1 | Breast Neoplasms | |
|
|
| Map3k7 | Prostatic Neoplasms | |
| Mapk10 | Epileptic encephalopathy, Lennox-Gastaut type | | Mapk8ip1 | Diabetes Mellitus, Type 2 | |
| Mapk8ip3 | Reperfusion Injury | | Mapk8 | Anti-Glomerular Basement Membrane Disease , Aortic Aneurysm, Abdominal , Brain Ischemia , Cardiomegaly , Hypertension , Myocardial Reperfusion Injury , Pulmonary Disease, Chronic Obstructive , Stroke | | Mapk9 | Arteriosclerosis , Precancerous Conditions | | Rac1 | Cardiomegaly , Heart Failure , Hypertrophy, Left Ventricular | | Spp1 | Acute Kidney Injury , Albuminuria , Aneurysm , Angina Pectoris , Anti-Glomerular Basement Membrane Disease , Arthritis, Rheumatoid , Biliary Atresia , Calcinosis , Carcinoma, Endometrioid , Carcinoma, Hepatocellular , Carcinoma, Non-Small-Cell Lung , Cardiomegaly , Coronary Artery Disease , Coronary Restenosis , Diabetes Mellitus, Experimental , Diabetic Nephropathies , Encephalomyelitis , Fibrosis , Foreign-Body Reaction , Glioma , Glomerulonephritis , Glomerulosclerosis , Hepatitis , Hepatitis C, Chronic , Hypertension, Renovascular , Inflammation , Kidney Calculi , Laryngeal Neoplasms , Liver Cirrhosis, Experimental , Malaria , Melanoma , Multiple Myeloma , Multiple Sclerosis , Myocardial Infarction , Myocardial Reperfusion Injury , Myocarditis , Neoplasm Metastasis , Neoplasms, Cystic, Mucinous, and Serous , Neovascularization, Pathologic , Neuritis, Autoimmune, Experimental , Ovarian Neoplasms , Pancreatic Neoplasms , Polycystic Kidney, Autosomal Dominant , Prostatic Neoplasms , Radiculopathy , Renal Insufficiency , Scrapie , Seizures , Spinal Cord Injuries , Stomach Neoplasms , Thyroid Neoplasms , Trauma, Nervous System , Tuberculosis , Urinary Bladder Neoplasms , Urinary Calculi | |
|
| Malaria | Spp1 | | Pancreatic Neoplasms | Map2k4 , Spp1 | | Calcinosis | Spp1 | | Inflammation | Spp1 | | Renal Insufficiency | Spp1 | | Obesity | Dusp1 | | Seizures | Dusp1 , Spp1 | | Epileptic encephalopathy, Lennox-Gastaut type | Mapk10 | | Diabetes Mellitus, Type 2 | Mapk8ip1 | | Aneurysm | Spp1 | | Cardiomegaly | Rac1 , Mapk8 , Spp1 | | Stomach Neoplasms | Spp1 | | Ovarian Neoplasms | Dusp1 , Map2k4 , Map2k7 , Spp1 | | Polycystic Kidney, Autosomal Dominant | Spp1 | | Melanoma | Spp1 | | Arteriosclerosis | Dusp1 , Mapk9 | | Acute Kidney Injury | Spp1 | | Breast Neoplasms | Dusp1 , Map3k1 | | Rhinitis | Cdc42 | | Urinary Bladder Neoplasms | Dusp1 , Map2k4 , Spp1 | | Alzheimer Disease | Cdc42 | | Arthritis, Rheumatoid | Spp1 | | Diabetes Mellitus, Type 1 | Dusp1 | | Thyroid Neoplasms | Spp1 | | Fibrosis | Spp1 | | Epilepsy, Temporal Lobe | Cdc42 | | Hypertension | Dusp1 , Mapk8 | | Prostatic Neoplasms | Spp1 , Dusp1 , Map2k4 , Map3k7 , Map2k7 | | Carcinoma, Hepatocellular | Spp1 | | Kidney Calculi | Spp1 | | Urinary Calculi | Spp1 | | Laryngeal Neoplasms | Spp1 | | Hypertension, Portal | Dusp1 | | Hepatitis | Spp1 | | Neovascularization, Pathologic | Spp1 | | Biliary Atresia | Spp1 | | Glomerulonephritis | Spp1 | | Albuminuria | Spp1 | | Angina Pectoris | Spp1 | | Arthritis, Experimental | Cdc42 | | Glioma | Spp1 | | Bipolar Disorder | Cdc42 | | Neoplasms, Cystic, Mucinous, and Serous | Spp1 | | Carcinoma, Non-Small-Cell Lung | Spp1 | | Brain Ischemia | Mapk8 | | Precancerous Conditions | Mapk9 | | Coronary Artery Disease | Spp1 | | Neoplasms | Spp1 | | Diabetes Mellitus, Experimental | Dusp1 , Spp1 | | Diabetic Nephropathies | Spp1 | | Heart Failure | Rac1 | | Encephalomyelitis | Spp1 | | Fibrosarcoma | Cdc42 | | Foreign-Body Reaction | Spp1 | | Trauma, Nervous System | Spp1 | | Hypertension, Renovascular | Spp1 | | Multiple Myeloma | Spp1 | | Liver Cirrhosis, Experimental | Spp1 | | Neoplasm Metastasis | Spp1 | | Multiple Sclerosis | Spp1 | | Myocardial Infarction | Spp1 | | Myocarditis | Spp1 | | Neuritis, Autoimmune, Experimental | Spp1 | | Pancreatitis | Dusp1 , Dusp10 | | Radiculopathy | Spp1 | | Scrapie | Spp1 | | Spinal Cord Injuries | Cdc42 , Spp1 | | Tuberculosis | Spp1 | | Reperfusion Injury | Cdc42 , Mapk8 , Mapk8ip3 , Spp1 | | Myocardial Reperfusion Injury | Mapk8 , Spp1 | | Hypertrophy, Left Ventricular | Rac1 | | Aortic Aneurysm, Abdominal | Mapk8 | | Glucose Intolerance | Dusp1 | | Carcinoma, Endometrioid | Spp1 | | Carcinoma, Ductal, Breast | Map2k4 | | Prostatic Intraepithelial Neoplasia | Map2k4 , Map2k7 | | Hepatitis C, Chronic | Spp1 | | Anti-Glomerular Basement Membrane Disease | Dusp1 , Mapk8 , Spp1 | | Stroke | Mapk8 | | Coronary Restenosis | Spp1 | | Pulmonary Disease, Chronic Obstructive | Mapk8 , Map2k4 | | Glomerulosclerosis | Spp1 | |
|